您当前所在的位置:首页 > 产品中心 > 产品信息
利福平_分子结构_CAS_13292-46-1)
点击图片或这里关闭

利福平

产品号 R3501 公司名称 Sigma Aldrich
CAS号 13292-46-1 公司网站 http://www.sigmaaldrich.com
分子式 C43H58N4O12 电 话 1-800-521-8956
分子量 822.94022 传 真
纯 度 ≥97% (HPLC) 电子邮件
保 存 Chembase数据库ID: 134128

产品价格信息

请登录

产品别名

标题
Rifampicin
IUPAC标准名
(7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-N-(4-methylpiperazin-1-yl)carboximidoyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl acetate
IUPAC传统名
(7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-N-(4-methylpiperazin-1-yl)carboximidoyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl acetate
别名
利米定
甲哌利福霉素
3-(4-甲基-1-哌嗪基亚胺甲基)利福霉素SV

产品登记号

PubChem SID 24899363
EC号 236-312-0
CAS号 13292-46-1
Beilstein号 5723476
MDL号 MFCD00151389

产品性质

纯度 ≥97% (HPLC)
外观 faint-orange to red-brown powder
溶解度 H2O: soluble1.3 mg/mL (pH 4.3)
溶解度 DMSO: soluble100 mg/mL
溶解度 H2O: soluble2.5 mg/mL at 25 °C (pH 7.3)
GHS危险品标识 GHS07
GHS警示词 Warning
GHS危险声明 H302-H315-H319-H335
欧盟危险性物质标志 有害性(Harmful) 有害性(Harmful) (Xn)
个人保护装置 dust mask type N95 (US), Eyeshields, Gloves
GHS警示性声明 P261-P305 + P351 + P338
危险公开号 22-36/37/38
RTECS编号 VJ7000000
安全公开号 26-36
保存温度 -20°C
德国WGK号 3

产品详细信息

详细说明 (English)
Frequently Asked Questions
Live Chat and Frequently Asked Questions are available for this Product.
Biochem/physiol Actions
Inhibits the assembly of DNA and protein into mature virus particles.
Mode of Action: Inhibits initiation of RNA synthesis by binding to β-subunit of RNA polymerase.
Rifampicin inhibits the assembly of DNA and protein into mature virus particles. It inhibits initiation of RNA synthesis by binding to β-subunit of RNA polymerase, which results in cell death1.
Application
Rifampicin is used to treat Tuberculosis and Tuberculosis-related mycobacterial infections1. It is widely used as an antipruritic agent in the autoimmune cholestatic liver disease, primary biliary cirrhosis (PBC). It has been shown to cause hepatitis2.
Protocols & Applications
Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information

参考文献